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Abstract
Calcium phosphate cements can be handled in paste form and set in a wet medium after precipitation of calcium phosphate crystals 
in the implantation site. Depending on the products entering into the chemical reaction leading to the precipitation of calcium 
phosphates, different phases can be obtained with different mechanical properties, setting times and injectability. We tested a cement 
composed of a powder, containing b-tricalcium phosphate (b-TCP) and sodium pyrophosphate mixed with a solution of phosphoric 
and sulphuric acids. The cement set under a dicalcium phosphate dihydrate (DCPD)-based matrix containing b-TCP particles. This 
was injected with a syringe into a defect drilled in rabbit condyles, the control being an identical defect left empty in the opposite 
condyle. The condyles were analysed histologically 2, 6 and 18 weeks after implantation. After injection into the bone defect the 
cement set and formed a porous calcium phosphate structure. Two different calcium phosphate phases with different solubility rates 
could be identified by scanning electron microscopy (SEM) observation. The less-soluble fragments could be degraded by cell 
phagocytosis in cell compartments of low pH or integrated in the newly formed bone matrix. The degradation rate of the material was 
relatively high but compatible with the ingrowth of bone trabeculae within the resorbing material. The ossification process was 
different from the creeping substitution occurring at the ceramic contact. Bone did not form directly at the cement surface following 
the differentiation of osteoblasts at the material surface. The trabeculae came to the material surface from the edges of the 
implantation site. Bone formation in the implantation site was significantly higher than in the control region during the first week of 
implantation. In conclusion, this material set in situ was well tolerated, inducing a mild foreign-body reaction, which did not impair its 
replacement by newly formed bone within a few weeks.
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1. Introduction
Self-setting calcium phosphate cements are materials
that can be handled by the surgeon in paste form and
injected into bone cavities or defects. They then set to
form a mineral matrix at the contact of which healing
bone tissue can form. Replacement of the mineral by
bone is supposed to occur as a result of the same process
taking place at the calcium phosphate ceramic contact.
These matrices result from the precipitation of a calcium
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phosphate phase different from the one in suspension in
the paste. The strength of the cement is given by the
entanglement of the growing mineral crystals. To obtain
a calcium phosphate cement with mechanical properties
compatible with surgical use, the raw material in solution
must be able to dissolve and recrystallize properly.
Calcium phosphate cements were originally developed
to act as osteoconductive materials able to take the exact
shape of the cavity to be filled and injectable with a sy-
ringe without requiring an open way through the tissues.
This concept is not new: plaster of Paris which consists of
calcium sulphate was used in such a way by Dreesman in
1892 [1]. Brown and Chow [2] were the first to develop
and patent a calcium orthophosphate cement.
Numerous components can enter into the chemical
reaction leading to calcium phosphate precipitation.
Driessens and co-workers [3, 4] listed the different cal-
cium phosphates that could be formed at temperatures
close to room temperature and known to be biocompat-
ible. More than 100 different formulations of calcium
orthophosphate cements were subjected to determina-
tions of the compressive strength and the diametral ten-
sile strength after storage at room temperature for 24 h
under 100% relative humidity. The setting occurred on
more than 15 formulations. These cements could be
divided into four classes: dicalcium phosphate dihydrate,
calcium and magnesium phosphates, octocalcium phos-
phate and non-stoichiometric apatite cements.
Mirtchi et al. [5] developed an orthophosphate cement
based on mixtures of monocalcium phosphate monohy-
drate (MCPM) and b-tricalcium phosphate (b-TCP)
with water.
We have developed a new calcium phosphate hydrau-
lic cement that can set in a wet environment and be
injected with a syringe into a bone defect or fracture site.
The cement consists of a solid phase containing b-TCP
and sodium pyrophosphate and a liquid phase composed
of orthophosphoric and sulphuric acid. The setting reac-
tion can be summarized as follows:
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This acid—base reaction can be divided into three stages:
(1) tricalcium phosphate dissolution; (2) nucleation; (3)
dicalcium phosphate growth. The physico-chemical prop-
erties of the cement can be modified by the purity and the
granulometry of the tricalcium phosphate. Dicalcium
phosphate is known to be one of the most soluble of
calcium phosphate phases [6] and can be useful when
material degradable within a few weeks is needed.
The aim of the described experiment was to check that
the material set when injected by syringe into a bone
cavity, and to examine the short-term effects of the ma-
terial on the surrounding tissues.
2. Materials and methods
2.1. Animals
The animals used for experiments were nine female
New Zealand white rabbits aged 6—7 months with body
weights of 3700—5100 g and which had free access to food
and water. The animals were observed daily for 1 week
after implantation and three times a week for the remain-
ing implantation period. The skin in the implanted re-
gion, animal mobility and behaviour were noted.
2.2. Material injected
Powder: 3 g (b-TCP, 2.954 g; anhydrous sodium pyro-
phosphate, 0.046 g). Liquid: 1.8 ml (phosphoric acid (4 M)
and sulphuric acid (0.1 M) solution). In this study, the
powder/liquid ratio was 1.3 and the conversion rate 95%.
The resulting solid material consisted of 95% of dihy-
drated dicalcium phosphate (DCPD), 4% of b-TCP and
1% of various mineral phases (sodium based and calcium
sulphate). The density was 1.43, the porosity 45% and the
mean pore diameter 7.1 lm.
2.3. Injection of bone cement
The cement was inserted under anaesthesia with intra-
muscular ketamine, through a lateral longitudinal skin
incision over the knee, in holes drilled in the external
condyles of rabbits. Holes were drilled in the external
condyles of the right and left legs. The left hole was filled
with the cement and the right hole was left empty as
control.
Each hole was 4 mm in diameter and 5 mm in length.
The cement was injected through a syringe in paste form
as follows:
f the liquid phase was poured in a polyethylene bowl
f the solid phase was added to the liquid at t"0
f the mixture was blended with a spatula for 30 s to
obtain a homogeneous mixture
f the cement was poured into a syringe and left to
rest
f it was then injected into the cavity after about 4 min
f the cement was left to set for 10 min without any
further manipulation
Three animals were killed by nembutal injection after
2, 6 and 18 weeks and the distal extremities of the femurs
were collected.
2.4. Histological processing
The samples were fixed in a 4% formaldehyde solution
for 48 h, dehydrated in increasing ethanol solution then
embedded in poly(methyl methacrylate (PMMA)). Sec-
tions 5-lm thick were obtained with a hard tissue
microtome (Reichert-Jung Type E). They were then
stained with Giemsa solution and by the Von Kossa
method.
The remaining histological blocks were gold/palla-
dium-coated and observed by scanning electron micro-
scopy (SEM) under a back-scattered mode operated at
10 kV.
Qualitative and quantitative studies were performed
on the longitudinal histological sections made through
the cylinder centre. The histomorphometry measure-
ments were obtained on an equal surface for each section.
The measurement zones were centred either on the
middle of the implant or the middle of the control zone.
The measurements were carried out on the entire implant
or control site on each section. Three sections were
located very close to the cylinder centre (less than
100 lm). Five primary measurements were taken to
characterize the structure of the newly formed bone at
the implanted site:
f Trabecular bone surface was defined as the bone sur-
face to total tissue surface ratio (BS/TS). The bone
surface comprised the mineralized and the osteoid
surfaces. The total tissue surface consisted of the bone
surface, bone marrow, stromal tissue and the calcium
phosphate implant.
f The relative osteoid surface (OS/BS) measures the per-
centage of the trabecular bone surface that is osteoid.
f The active osteoid surface Ob.S/BS measures the per-
centage of trabecular surface lined by osteoblasts.
f The relative eroded surface (ES/BS) measures the per-
centage of trabecular surface eroded by osteoclasts.
We defined another parameter that, unlike the pre-
vious, was not in the report of the ASBMR histo-
morphometry nomenclature committee [7], the implant
surface (IS/TS). The measures were obtained using a
computerized image analysis device coupled to a Reicher
Polyvar microscope.
2.5. Statistical analysis
The measures were obtained on three sections for each
implanted site. Statistical analyses were carried out ac-
cording to a two-way analysis of variance (ANOVA) test.
3. Results
3.1. Qualitative histology
3.1.1. After 2 weeks
The implantation zone was occupied by a solid cylin-
der made of mineral grains that had been partly removed
from the section by the microtome blade. Thin newly-
formed trabeculae originating from the cortical zone
were inserted perpendicularly to the implant surface.
These trabeculae were surrounded by an osteoid layer
lined with active osteoblasts. Bone marrow cavities be-
tween these trabeculae were filled with connective tissue
containing many fibroblast-like cells and bone trabeculae
fragments (Figs. 1 and 2). No haematopoietic cell could
be found in these bone marrow cavities at this time.
Some cell condensations at the origin of connective
tissue trabeculae could be seen in the vicinity of the
implant, some of which were synthesizing an extracellu-
lar matrix (ECM) undergoing mineralization. Resorption
marks were apparent at the implant surface into which
the tissue had grown.
In one sample, the inner part of the cylinder was
surrounded by a thin layer of cellular connective tissue
(Fig. 3).
A few mineral grains had become detached from the
implants and were found free in the connective tissue in
the bone marrow cavities or even included within the
Fig. 1. Subperiosteal region of the cylinder (cp) in contact with newly
formed bone trabeculae 2 weeks after implantation. The material was
removed from the section by the microtome blade. Bar"300 lm.
Fig. 2. Interface bone—material on the same section as in Fig. 1. Bone
trabeculae (T) are apposed at the material surface and coated with
osteoid tissue (P) lined with osteoblasts (P). Grains of material are
found in the bone marrow cavity. Bar"100 lm.
Fig. 3. Tissue—material interface in the mid-region of the same implant
(cp) as in Fig. 1. The external part is in contact with newly formed bone
tissue while the inner part is surrounded by dense connective tissue (ft)
with collagen bundles parallel to the material surface. Bar"300 lm.
bone matrix. Some of them had been phagocytosed into
macrophages. These grains were round in shape and did
not exceed 12 lm in size.
SEM showed that the material consisted of small white
particles disseminated within a grey matrix with some
micropores. Several grey-levels were visible in the matrix
suggesting an unhomogeneous setting (Figs. 4—6).
The control bone defect was filled with loose connect-
ive tissue in the form of a network with connective tissue
trabeculae several tens of a micrometre in thickness.
Ossification had begun at the edges of the defect.
3.1.2. After 6 weeks
One implant was almost degraded, with some frag-
ments of a few hundred micrometres present and
surrounded by immature bone trabeculae and un-
mineralized osteoid tissue (Figs. 7—9). The amount and
localization of this osteoid was unusual. Some calcium
phosphate particles were found within the periosteum.
A hyperplasic reaction of the periosteum had occurred.
However, around these particles, no macrophage was
evidenced.
Other implants showed a mineral core which still ap-
peared as a solid. The region beneath the cylinder surface
had been invaded by bone trabeculae. The bone marrow
cavities between the trabeculae were completely filled
with implant fragments. These fragments embedded
within the bone tissue contained cells between the crys-
tals. The bone trabeculae structure was immature with
many remodelling marks. An organic matrix was visible
in some sites at the implant surface. Many grains de-
tached from the material were phagocytosed by macro-
phages and gaint cells.
SEM revealed the presence of material fragments far
from the implantation zone in the condyle. A dissolution
zone of thickness 100 to 300 lm could be observed under
the material surface in one implant. Mineralizing bone
trabeculae were ingrowing in this zone. The material core
lined by this dissolution zone was edged by a densified
layer less than 100-lm thick (Fig. 10).
The control defects were occupied by low-density tra-
becular bone in which the bone marrow cavities con-
tained cytologically normal marrow.
3.1.3. After 18 weeks
Small grains emitted by the material were less numer-
ous in the bone marrow cavities surrounding the frag-
mented materials. The remaining implants were
fragmented with two or three big fragments totally lined
by bone trabeculae parallel to the fragment surfaces. This
lining bone layer was linked to the cortical bone by bone
trabeculae.
The SEM showed that the material was a solid with
pores ranging from a few to a hundred micrometres.
White grains of different sizes ranging from one or two to
several tens of micrometres were dispersed within a grey
Fig. 4. Backscattered SEM of a 2-week implanted cement (C). Very
immature bone trabeculae (P) and bone fragments are in contact with
the implant surface. The implant shows different grey levels due to
different densities suggesting that the cement did not set homogene-
ously after implantation. Some implant fragments are detached from
the surface. Bar"1 mm.
Fig. 5. SEM of the section surface of an implant after 2 weeks showing
interconnected crystals with pores within the matrix. Bar"10 lm.
Fig. 6. Backscattered SEM of the section of a 2-week implanted cement
showing white particles identified as b-TCP disseminated within a grey
matrix with irregular porosity identified as DCPD. Bar"100 lm.
Fig. 7. Fragments of a 6-week implanted cylinder (w) separated by
bone trabeculae showing cemented lines ( ) probably indicating the
start of the growth period. Bar"200 lm.
Fig. 8. Implant fragments (w) embedded within immature bone
6 weeks after implantation. Most of the fragment volume contains cells
whose nuclei are visible (blue dots). Bar"250 lm.
Fig. 9. High magnification of the interface between the bone (j) and
the mineral matrix (d). An organic matrix has invaded the matrix
porosity. The grains are dissociated and the matrix is not mineralized.
Bar"250 lm.
Fig. 10. Backscattered SEM of the dissolution zone (DZ) principally
affecting the DCPD matrix beneath its surface. The core of the cylinder
(C) is lined with a densified layer (DL) of material. Bar"100 lm.
Fig. 11. Backscattered SEM of a fragment of an 18-week implanted
cylinder of microporous structure on which bone trabeculae are ap-
posed. Bar"1 mm.
matrix (Figs. 11 and 12). Bone matrix showing different
grey levels was in contact with the material. Some white
particles could be found in the Havers canals and were
probably grouped within the histiocytes. Some such par-
ticles were included within the bone matrix.
The control zones were difficult to differentiate from
the rest of the bone tissue. However, the low density of
trabeculae in this region was characteristic of the control
zone.
3.2. Histomorphometry
As shown by the implant surface (IS) measurements,
the implant degraded during the implantation time
Table 1. One quarter of the implant surface section re-
mained after 18 weeks. During the first 6 weeks of im-
plantation, there was a significant increase in the amount
of bone trabeculae in the sites implanted with the cement
Table 1
Histomorphometric measurements made on the different sections expressed as a percentage
Implantation time TBS IS AOS ROS RES
(weeks)
Implant Control Implant Control Implant Control Implant Control Implant Control
2 24.25 14.85 46 0 9 12.12 10.62 6.15 0.27 0.032
(11.75) (11.25) (16.15) (1) (0.77) (0.62) (5.15) (0.07) (0.025)
6 31.4 21.87 31.83 0 11.66 (1 7.25 (1 0 0
(11.12) (7.33) (15.27) (11.32) (0.25)
18 22.35 23.5 11 0 (1 (1 (1 (1 0 0
(5.6) (7.9) (5.5)
Abbreviations: TBS, trabecular bone surface (BS/TS); IS, implant surface (IS/TS); AOS, active osteoid surface (Ob.S/BS); ROS, relative osteoid
surface (OS/BS); RES, relative eroded surface (ES/BS).
Mean values with standard deviation in parentheses.
Fig. 12. Higher magnification of the bone—material interface observed
by backscattered SEM 18 weeks after implantation. Some degradation
marks (N) are visible at the material surface. The bone matrix shows
different grey levels with the light grey zone having a very high cellular-
ity characteristic of immature bone suggesting the occurrence of bone
matrix ( ) maturation. Bar"100 lm.
compared to the control sites. At 6 weeks, bone forma-
tion as indicated by the active osteoid surface (AOS) and
relative osteoid surface (ROS) measurements was still
significantly higher in the sites implanted with cements
than in the control sites.
4. Discussion
This study showed that:
f The cement set when injected into a bone marrow
cavity and formed a porous calcium phosphate struc-
ture.
f Two different calcium phosphate phases with different
solubility rates could be identified by SEM observa-
tion. The small white granules disseminated in the
matrix were probably made of b-TCP granules be-
cause the density (TCP"3.14) was higher than that of
DCPD (2.83). Furthermore the difference was in-
creased by the TCP sintering during powder manufac-
ture.
f A mild foreign-body reaction occurred in the vicinity
of the material with a majority of mononucleated cells.
Calcium phosphate particles were phagocytosed in
these cells.
f The degradation rate of the material was relatively
high when compared to the usual hydroxyapatite (HA)
and TCP ceramics but compatible with the ingrowth
of bone-forming trabeculae within the resorbing ma-
terial.
Different fast-setting calcium phosphates have been
described [3, 4, 8, 9—12] that all show osteoconductive
properties and can be injected. These cements are gener-
ally the product of an acid—base reaction. The reaction
pH, which was not measured in this experiment, has
proved to be low in vitro and did not seem to induce any
necrosis as no dead tissue zone was visible 2 weeks after
implantation. Ohura et al. [13] described the implanta-
tion of a DCPD-based cement obtained from a mixture
of MCPM (monocalcium phosphate monohydrated) and
b-TCP to which calcium sulphate hemihydrate had been
added. The samples were set during the intervention
outside the body and implanted when solid. They con-
cluded that these cements stimulated bone formation and
were rapidly integrated by bone tissue.
In this experiment, the dissolution products induced
a low foreign-body reaction. However, the presence of
macrophages and gaint cells in the implantation site did
not impair bone formation within the same site. Some
differentiating osteoblasts synthesizing an osteoid matrix
were identified among the macrophages. No increase in
bone resorption could be detected at any time.
The ossification process occurring at the material con-
tact was not identical to that taking place at the contact
of calcium phosphate ceramics. Osteoblast differenti-
ation preferentially occurs at the calcium phosphate ce-
ramic surface and leads to the presence of an osteoblast
line which synthesizes an osteoid matrix and then an
immature bone. Once the material surface has been
coated by an immature bone layer, the bone then extends
to the entire pore volume.
In contrast, osteoblasts are not, or very rarely, found at
the cement surface. Most of the osteoblasts differentiate at
some distance from the cement and there is ingrowth of
the forming bone trabeculae from the implantation cavity
edges into the spaces made available by material resorp-
tion. An interposition of a metachromatic matrix between
some trabeculae and the cement during the early stages
of implantation is in agreement with trabecular ingrowth.
It is difficult to explain such differences in the ossifica-
tion process. The high surface area of the material asso-
ciated with the high solubility of the matrix could induce
a microenvironment with a different physico-chemistry
from that of the ceramic. The instability of the resorbing
surface of the material could also have a role in these
differences. The resorption could be too fast to allow
bone apposition at the material surface.
5. Conclusions
This formulation gives a fast-setting calcium phos-
phate showing ability to be replaced by bone tissue
although a foreign-body reaction was detected. Setting
was effective in a wet environment and particularly in
bone. The degradation rate of the material was compat-
ible with ingrowth of the bone tissue within the degrad-
ing cement. The cylinders were degraded within a matter
of weeks making it possible to use this matrix as a carrier
for molecules under such physico-chemical setting condi-
tions. The ossification process which took place at the
material contact was different from that occurring at the
ceramic contact.
References
[1] Dreesman H. Uber Knochenplombierung Beitre. Klin Chir 1892;
9:804—807.
[2] Brown W, Chow LC. Combinations of sparingly soluble calcium
phosphates in slurries and paste as mineralizers and cements. US
Patent No. 4612053, 1986.
[3] Driessens FCM, Boltong MG, Bermudez O, Planell JA. Formula-
tion and setting times of some calcium orthophosphate cements:
a pilot study. J Mater Sci: Mater Med 1993;4:503—508.
[4] Driessens FCM, Boltong MG, Bermudez O, Planell JA, Ginebra
MP, Fernandez E. Effective formulations for the preparation of
calcium phosphate bone cements. J Mater Sci: Mater Med
1994;5:164—170.
[5] Mirtchi AA, Lemaı¨tre J, Munting E. Calcium phosphate cements
action of setting regulators on the properties of the b-tricalcium
phosphate—monocalcium phosphate cements. Biomaterials 1989;
10:634—39.
[6] Nancollas H. In vitro studies of calcium phosphate crystallisation.
In: Mann S, Webb J, Williams RJP, editors. Biomineralization.
Chemical and biochemical perspectives. New York: VCH,
1989:157—182.
[7] Parfitt AM, Drezner MK, Glorieux FH et al. Bone histomor-
phometry: standardization of nomenclature, symbols and units.
Report of the ASBMR nomenclature committee. J Bone Miner
Res 1987;2:595—610.
[8] Ishikawa K, Takagi S, Chow LC, Ishikawa Y. Properties and
mechanisms of fast-setting calcium phosphate cements. J Mater
Sci: Mater Med 1996;17:1429—32.
[9] Kurashina K, Kurita H, Hirano M, de Blieck JMA, Klein CPAT,
de Groot K. Calcium Phosphate cement: in vitro and in vivo
studies of the a-tricalcium phosphate—dicalcium phosphate
dibasic—tetracalcium phosphate monoxide system. J Mater Sci:
Mater Med 1995;6:343—47.
[10] Constanz BR, Ison IC, Fulmer MT et al. Skeletal repair by in situ
formation of the mineral phase of bone. Science 1995;
267:1796—99.
[11] Bermudez O, Boltong MG, Driessens FCM, Planell JA. Develop-
ment of some calcium phosphate cements from combination of
a-TCP, MCPM and CaO. J Mater Sci: Mater Med 1994;
5:160—63.
[12] Miyamato Y, Ishikawa K, Fukao H et al. In vivo setting behav-
iour of fast-setting calcium phosphate cement. Biomaterials 1995;
16:855—60.
[13] Ohura K, Bohner M, Hardouin P, Lemaitre J, Pasquier G,
Flautre B. Resorption of, and bone formation from, new b-trical-
cium phosphate—monocalcium phosphate cements: an in vivo
study. J Biomed Mater Res 1996;30:193—200.
[14] Frayssinet P, Trouillet JL, Rouquet N, Azimus E, Autefage A.
Osseointegration of macroporous calcium phosphate ceramics
having a different chemical composition Biomaterials 1993;
14:423—29.
